Watchlist Price Alert

Sumitomo Pharma Co. Ltd. (DNPUF)

PNK: DNPUF · Real-Time Price · USD

6.53

0.73 (12.59%)

At close: May 02, 2025, 1:24 PM

Sumitomo Pharma Income Statement

Financials in JPY. Fiscal year is April - March.

Fiscal Year	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019	Q4 2018	Q3 2018	Q2 2018	Q1 2018	Q4 2017	Q3 2017	Q2 2017	Q1 2017	Q4 2016	Q3 2016	Q2 2016	Q1 2016
Period Ending	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017	Sep 30, 2017	Jun 30, 2017	Mar 31, 2017	Dec 31, 2016	Sep 30, 2016	Jun 30, 2016	Mar 31, 2016	Dec 31, 2015	Sep 30, 2015	Jun 30, 2015
Revenue	90.67B	79.53B	82.39B	76.96B	75.69B	95.28B	140.98B	159.41B	159.88B	127.96B	138.34B	162.53B	131.2B	121.19B	133.26B	127.64B	133.86B	125.72B	126.41B	113.12B	117.48B	112.4B	120.72B	110.24B	115.91B	102.72B	123.8B	115.18B	116.3B	106.14B	107.41B	94.6B	103.49B	98.68B	105.61B	100.8B	98.12B
Cost of Revenue	34.95B	33.39B	32.87B	29.89B	30.43B	39.15B	46.92B	46.78B	46.06B	39.29B	40.98B	38.38B	38.48B	32.98B	34.1B	34.72B	35.97B	36.33B	37.06B	27.33B	28.95B	28.37B	29.59B	26.68B	28.91B	19.18B	31.42B	29.53B	29.52B	25.73B	26.45B	23.96B	23.93B	25.41B	26.98B	25.74B	26.34B
Gross Profit	55.73B	46.14B	49.52B	47.06B	45.26B	56.13B	94.05B	112.63B	113.82B	88.67B	97.36B	124.16B	92.72B	88.21B	99.16B	92.92B	97.89B	89.38B	89.36B	85.79B	88.53B	84.02B	91.13B	83.56B	87B	83.54B	92.39B	85.66B	86.78B	80.4B	80.96B	70.64B	79.56B	73.27B	78.63B	75.06B	71.77B
Operating Income	-3.1B	-48.53B	-31.25B	-34.93B	-51.57B	-59.2B	11.14B	-43.53B	14.61B	2.01B	10.66B	39.27B	8.31B	-16.31B	40B	24.27B	23.27B	1.78B	14.63B	26.41B	40.42B	11.05B	17.22B	13.79B	15.81B	32.23B	11.43B	27.84B	19.73B	8.52B	17.51B	12.18B	14.55B	5.84B	14.24B	12.4B	4.44B
Interest Income	22.33B	20.73B	n/a	10.71B	21.32B	9.57B	n/a	18.82B	32.88B	16.13B	6.44B	2.59B	611M	6.53B	392M	86M	645M	244M	5.65B	908M	1.43B	872M	n/a	3.24B	4.88B	1.66B	1.48B	1.13B	169M	127M	173M	216M	230M	227M	154M	129M	117M
Pretax Income	17.2B	-217.92B	-49.06B	-25.07B	-31.05B	-50.11B	-18.84B	-25.58B	46.61B	17.38B	16.32B	41.31B	7.96B	-1.87B	36.07B	21.68B	21.98B	-475M	20.27B	27.24B	36.91B	11.88B	15.56B	16.97B	20.63B	28.82B	12.79B	28.97B	19.84B	2.53B	26.99B	5.01B	12.69B	2.62B	13.51B	12.85B	10.58B
Net Income	15.94B	-197.26B	-49.97B	-28.88B	-38.86B	-56.01B	-11.22B	-38.39B	31.11B	10.05B	9.91B	31.65B	4.8B	-14.04B	32.96B	19.04B	18.26B	-3.23B	13.65B	23.63B	6.7B	8.66B	12.1B	12.62B	15.25B	2.86B	-1.44B	20.71B	14.41B	-580M	18.65B	2.56B	8.37B	1.35B	10.13B	7.27B	5.94B
Selling & General & Admin	45.36B	55.68B	57.51B	59.15B	74.89B	83.85B	81.56B	130.62B	77.29B	60.05B	64.36B	62.61B	62.06B	43.35B	52.85B	45.16B	49.01B	56.55B	50.77B	19.14B	27.89B	30.98B	50.44B	48.77B	50.25B	30.01B	55.82B	46.15B	37.15B	42.58B	44.03B	40.06B	45.67B	38.63B	45.64B	42.56B	47.22B
Research & Development	13.12B	38.99B	23.29B	22.51B	27.84B	55.86B	26.02B	25.56B	24.42B	27.12B	22.08B	23.28B	22.43B	61.01B	22.46B	23.46B	25.74B	31.42B	23.55B	40.09B	20.06B	40.4B	20.65B	20.46B	20.86B	19.02B	22.78B	20.41B	19.93B	23.65B	19.42B	18.41B	19.34B	23.08B	18.75B	20.09B	20.11B
Other Expenses	349M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-126M	-403M	-167M	-118M	-114M	352M	-665M	-322M	-114M
Operating Expenses	58.83B	94.67B	80.77B	81.99B	96.82B	115.33B	82.91B	156.16B	99.21B	86.67B	86.7B	84.89B	84.41B	104.52B	59.17B	68.65B	74.62B	87.61B	74.73B	59.37B	48.11B	72.97B	73.9B	69.77B	71.19B	51.31B	80.96B	57.81B	67.05B	71.88B	63.45B	58.47B	65.01B	67.43B	64.39B	62.65B	67.33B
Interest Expense	2.02B	1.54B	17.82B	851M	800M	480M	29.98B	866M	883M	762M	778M	550M	960M	n/a	4.32B	2.68B	1.94B	2.5B	4.66B	81M	4.95B	41M	37M	61M	68M	5.45B	115M	31M	117M	157M	149M	158M	167M	213M	235M	237M	234M
Selling & Marketing Expenses	n/a	-182.3B	n/a	n/a	n/a	59.86B	n/a	n/a	n/a	37.78B	n/a	n/a	n/a	37.36B	n/a	n/a	n/a	37.74B	n/a	n/a	n/a	37.98B	n/a	n/a	n/a	38.21B	n/a	n/a	n/a	24.08B	n/a	n/a	n/a	26.96B	n/a	n/a	n/a
Cost & Expenses	93.78B	128.06B	113.63B	111.89B	127.25B	154.48B	129.84B	202.94B	145.26B	125.96B	127.69B	123.27B	122.89B	137.5B	93.27B	103.37B	110.59B	123.94B	111.79B	86.71B	77.06B	101.34B	103.49B	96.45B	100.1B	70.49B	112.38B	87.34B	96.56B	97.62B	89.9B	82.43B	88.94B	92.83B	91.37B	88.4B	93.67B
Income Tax Expense	1.27B	-20.69B	899M	3.8B	7.81B	13.97B	-1.46B	17.76B	18.52B	11.96B	11.12B	12.13B	7.15B	19.2B	8.5B	6.9B	6.41B	7.59B	6.63B	3.61B	30.2B	3.23B	3.46B	4.35B	5.38B	25.96B	14.23B	8.26B	5.43B	3.11B	8.34B	2.45B	4.32B	1.27B	3.38B	5.58B	4.63B
Shares Outstanding (Basic)	397.29M	397.29M	397.29M	397.29M	397.29M	397.29M	397.29M	397.29M	397.29M	397.29M	397.29M	397.29M	397.29M	397.29M	397.29M	397.29M	397.3M	397.3M	397.3M	397.3M	397.3M	397.3M	397.3M	397.3M	397.3M	397.3M	397.3M	397.3M	397.3M	397.3M	397.3M	397.3M	397.3M	397.3M	397.3M	397.3M	397.3M
Shares Outstanding (Diluted)	397.29M	397.29M	397.29M	397.29M	397.29M	397.29M	397.29M	397.29M	397.29M	397.29M	397.29M	397.29M	397.29M	397.29M	397.29M	397.29M	397.3M	397.3M	397.3M	397.3M	397.3M	397.3M	397.3M	397.3M	397.3M	397.3M	397.3M	397.3M	397.3M	397.3M	397.3M	397.3M	397.3M	397.3M	397.3M	397.3M	397.3M
EPS (Basic)	40.11	-496.52	-125.77	-72.68	-97.81	-140.98	-28.24	-96.63	78.30	25.31	24.94	79.66	12.09	-35.33	82.96	47.92	45.96	-8.12	34.35	59.47	16.87	21.79	30.46	31.77	38.38	24.05	-3.63	52.13	36.27	-1.46	46.94	6.43	21.06	3.40	25.50	18.31	14.95
EPS (Diluted)	40.11	-496.52	-125.77	-72.68	-97.81	-140.98	-28.24	-96.63	78.30	25.31	24.94	79.66	12.09	-35.33	82.96	47.92	45.96	-8.12	34.35	59.47	16.87	21.79	30.46	31.77	38.38	24.05	-3.63	52.13	36.27	-1.46	46.94	6.43	21.06	3.40	25.50	18.31	14.95
EBITDA	3.8B	-227.89B	-21.65B	-25.49B	-21.04B	-40.46B	20.86B	21.75B	26.13B	11.9B	20.74B	49.1B	16.58B	-25.18B	45.11B	29.37B	27.68B	5.92B	18.96B	30.73B	44.68B	17.94B	20.67B	17.33B	19.31B	37.75B	12.91B	34.24B	23.18B	2.69B	27.14B	5.16B	12.85B	2.84B	13.75B	13.09B	4.96B
EBIT	-3.1B	-216.38B	-31.25B	-24.22B	-30.25B	-49.63B	11.14B	-24.71B	47.49B	18.14B	17.09B	41.86B	8.92B	-8.22B	40.39B	24.35B	23.92B	2.02B	14.63B	27.32B	41.85B	11.93B	17.22B	17.03B	20.7B	34.26B	12.91B	27.84B	32.28B	8.52B	27.14B	5.16B	12.85B	2.84B	13.75B	13.09B	10.81B
Depreciation & Amortization	6.91B	9.51B	9.6B	9.44B	9.21B	9.17B	9.73B	10.85B	11.52B	10.16B	10.09B	9.83B	8.27B	8.05B	5.11B	5.1B	4.41B	4.46B	4.33B	4.32B	4.25B	3.5B	3.45B	3.53B	3.49B	3.49B	-83M	6.4B	3.08B	-3.88B	8.62B	-7.01B	-1.7B	-1.39B	-370M	-845M	517M